Division of Cardiothoracic Surgery, Department of Surgery, Westchester Medical Center, New York Medical College, Valhalla, New York.
Division of Cardiothoracic Surgery, Department of Surgery, Westchester Medical Center, New York Medical College, Valhalla, New York.
Ann Thorac Surg. 2022 Feb;113(2):569-576. doi: 10.1016/j.athoracsur.2021.03.090. Epub 2021 Apr 12.
This study reviews the outcomes of our reoperative total arch repair technique using a trifurcated graft and selective antegrade cerebral perfusion.
Fifty patients underwent reoperative total arch repair from January 2005 to September 2020, with either a one-stage repair (n = 9) or two-stage repair (n = 41). The two-stage technique includes minimal dissection of the mediastinal structures, an arch-first technique using a trifurcated graft, and construction of a classical elephant trunk through a partial transverse incision distally in the old graft or in the aorta just distal to the old graft.
The median age was 63 years. Chronic dissection was the most frequent indication (88%), and 98% had undergone a previous proximal aortic repair at a median interval of 3 years. The median cardiopulmonary bypass, myocardial ischemic, selective antegrade cerebral perfusion, and lower body circulatory arrest times were 226, 103, 97, and 98 minutes, respectively. The minimum nasopharyngeal and bladder temperature were 16.5°C and 20.0°C, respectively. Operative mortality was 2%, the incidence of stroke was 2%, and the incidence of spinal cord injury was 0%. Stage II repair was performed in 37 patients (open, 33 patients; endovascular, 4 patients), with 2 mortalities and no spinal cord injury. The median duration between stage I and II was 63 days. Survival and aortic event free rates at 3 years were 88.4% ± 4.9%, and 89.8% ± 5%, respectively.
We report a reoperative total arch repair technique that minimizes dissection of the cardiac structures, simplifies the distal anastomosis, and protects vital organs, such as the brain, heart, and spinal cord.
本研究回顾了我们使用三分支移植物和选择性顺行脑灌注进行再次全弓修复的结果。
2005 年 1 月至 2020 年 9 月,50 例患者接受了再次全弓修复,其中 9 例为一期修复,41 例为二期修复。二期技术包括对纵隔结构进行最小程度的解剖,使用三分支移植物进行弓部首先修复,以及通过在旧移植物的远端或就在旧移植物远端的主动脉上进行部分横切口构建经典的象鼻。
中位年龄为 63 岁。慢性夹层是最常见的指征(88%),98%的患者在前一次近端主动脉修复后中位间隔 3 年接受了再次手术。中位体外循环、心肌缺血、选择性顺行脑灌注和下半身循环阻断时间分别为 226、103、97 和 98 分钟。鼻咽和膀胱的最低温度分别为 16.5°C 和 20.0°C。手术死亡率为 2%,中风发生率为 2%,脊髓损伤发生率为 0%。37 例患者(开放 33 例,血管内 4 例)进行了二期修复,2 例死亡,无脊髓损伤。一期和二期之间的中位时间为 63 天。3 年的生存率和主动脉无事件生存率分别为 88.4%±4.9%和 89.8%±5%。
我们报告了一种再次全弓修复技术,该技术最大限度地减少了心脏结构的解剖,简化了远端吻合,并保护了大脑、心脏和脊髓等重要器官。